Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.94)

# 1,704

Out of 5,090 analysts

2

Total ratings

100%

Success rate

54.91%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic

Stocks Rated by Matt Dellatorre

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	VTRS Viatris	Initiates: Neutral	$10	$10.93	-8.51%	1	Jun 6, 2025
	TEVA Teva Pharmaceutical Industries	Initiates: Buy	$24	$28.46	-15.67%	1	Jun 6, 2025

Viatris

Jun 6, 2025

Initiates: Neutral

Price Target: $10

Current: $10.93

Upside: -8.51%

Teva Pharmaceutical Industries

Jun 6, 2025

Initiates: Buy

Price Target: $24

Current: $28.46

Upside: -15.67%